Date post: | 28-Oct-2014 |
Category: |
Documents |
Upload: | doctorjareer |
View: | 143 times |
Download: | 17 times |
INTRAVENOUS ANAESTHETIC
AGENTS
Dr. Med. Khaled Radaideh
Department of Anesthesiology - Jordan University of Science and Technology Irbid-Jordan
7 A
pr 2
02
3
1
Dr. M
ed. K
hale
d R
adaid
eh
INTRA VENOUS ANAESTHETIC AGENT
OBJECTIVES1- Properties of the ideal intravenous anesthetic agent
2- Classification of the intravenous anesthetic agent
3- Sodium Thiopental
3.1. Definition
3.2. Classification
3.3. Physical chemical properties
3.4. Pharmacokinetics
3.5. Pharmacodynamics
3.6. Dose and Administration
3.7. Indication, contraindication and precautions
3.8. Side Effects
7 A
pr 2
02
3
2
Dr. M
ed. K
hale
d R
adaid
eh
INTRA VENOUS ANAESTHETIC AGENT
OBJECTIVES4- Propofol4.1. Physical and chemical properties4.2. Dosage4.3. Effects on organ systems4.4. Indication and contraindication5. Ketamine5.1. definition of dissociative anesthesia5.2. Physical & chemical Properties5.3. Pharmacokinetics (Route of administration and Dosage)
5.4. Metabolism5.5. Mechanism of action5.6. Pharmacodynamics (effect on organ systems)5.7. Indications and contraindications
7 A
pr 2
02
3
3
Dr. M
ed. K
hale
d R
adaid
eh
INTRA VENOUS ANAESTHETIC AGENT
OBJECTIVES6- Benzodiazepines
6.1. Features
6.2. Mode of action
6.3. Midazolam and Diazepam (Uses, differences between them)
6.4. Benzodiazepine antagonists (Flumazenil)
7. Narcotic Agonists
7.1. Origin, Site of action and Receptors
7.2. Pharmacokinetics
7.3. Pharmacodynamics (effect on organ systems)
5.4. Fentanyl And Morphine
8. Narcotic Antagonists (Naloxone)
7 A
pr 2
02
3
4
Dr. M
ed. K
hale
d R
adaid
eh
PROPERTIES OF THE IDEAL INTRA VENOUS ANAESTHETIC AGENT{1 OF 3}
1-rapid onset: achieved by an agent that is mainly : A- un-ionized at blood ph(7.35 – 7.45) B- highly lipid soluble** these properties permit penetration of the BBB2-rapid recovery: -early recovery of consciousness is usually produced by rapid
redistribution of the drug from brain into other well-perfused tissues particularly muscles
-plasma conc. Of drug decreases & drug diffuses out of the brain along a conc. gradient
-quality of the recovery period is more related to the rate of metabolism of the drug
* Drugs with slow metabolism are with a more prolonged hangover effect (fatigue, weakness, pain, nuasea vomiting..etc )and accumulate if used in repeated doses or by infusion for maintenance of anesthesia
7 A
pr 2
02
3
5
Dr. M
ed. K
hale
d R
adaid
eh
3- analgesia at sub anesthetic concentrations*analgesia :an absence of the sense of pain without loss of consciousness
4- minimal cardiovascular and resp. depression
5- no emetic effects
6- no excitatory phenomenae.g. coughing .hiccup ,involuntary movements
7-no emergence phenomenae.g. nightmares
8-no interaction with neuromuscular blocking drugs(muscle relaxant)*Neuromuscular blocking drugs relax skeletal muscles and induce
paralysis.
PROPERTIES OF THE IDEAL INTRA VENOUS ANAESTHETIC AGENT {2 of 3} 7
Ap
r 20
23
6
Dr. M
ed. K
hale
d R
adaid
eh
9- no pain on injection
10- no venous sequelae(such as thrombosis)
11-no toxic effects on other organs
12- no release of histamine(bronchospasm ..itching)
13- no hypersensitivity reactions
14- water soluble formulation
15- long shelf life :The length of time a product may be stored without becoming unsuitable
for use or consumption.
16-no stimulation of porphyria
PROPERTIES OF THE IDEAL INTRA VENOUS ANAESTHETIC AGENT {3 of 3}
7 A
pr 2
02
3
7
Dr. M
ed. K
hale
d R
adaid
eh
INTRAVENOUS ANAESTHETIC AGENTS1- Barbiturate1.1. sodium thiopental(used
for over 40 years)2. Non barbiturate2.1. propofol (newly
introduced)2.2. ketamine (infrequently
used) 2.3. Etomidate4. other adjuvant intravenous
anesthetic agents (benzodiazepines, midazolam, diazepam,…)
7 A
pr 2
02
3
8
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL) Definition:
ultra short acting barbiturate
Classification:
IV anesthetic-hypnotic
Physical chemical properties :
-It’s a Yellow powder with a sulphuric smell and a bitter taste
-highly lipid soluble compound
-when combined with sodium carbonate it becomes water soluble
7 A
pr 2
02
3
9
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
-its bacteriostatic in water and has a ph of 10.6 to10.8
-*when injected ,sodium bicarbonate is neutralized and the thiopental is converted to its lipid soluble non ionazed form(40% ionized at ph=7.4)
-its highly protien bound by albumen(75%)
Which prevents precipition out of solution in vivo
7 A
pr 2
02
3
10
Dr. M
ed. K
hale
d R
adaid
eh
Supplied: thiopental(yellow powder) is dissolved in water& sodium carbonate to make a 2.5% solution (25mg/ml)
- -Its stable at room temp for 2 weeks
- Thiopental is a core medicine in the World Health Organization's "Essential Drugs List", which is a list of minimum medical needs for a basic health care system
Sodium thiopental (pentothal) 7
Ap
r 20
23
11
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
Pharmacokinetics-An IV dose of 3-5 mg/kg results in loss of
consciousness
-time required to render the patient unconscious is generally
30-60 secs after administration .this is called the “arm brain” circulation time
-arm brain circulation time is the time required for the drug to pass from site of
injection to the brain as it passes through the right heart ,pulmonary circ., and the left heart
7 A
pr 2
02
3
12
Dr. M
ed. K
hale
d R
adaid
eh
Pharmacokinetics-with no other drugs ,the anesthetic
state persists for 5-10 minsIts concentration is low enough in
the brain such that consciousness returns.
So is most commonly used in the induction phase of general anesthesia
As with all lipid soluble anesthetic drugs, the short duration of action of Sodium thiopental is almost entirely due to its redistribution away from central circulation towards muscle and fat tissue.
Sodium thiopental (pentothal) 7
Ap
r 20
23
13
Dr. M
ed. K
hale
d R
adaid
eh
Pharmacokinetics-sulphur containing drugs , acidosis, NSAIDS may displace
thiopental from albumen
-liver &renal disease may be associated with low albumin levelsso result in an increase in free thiopental which inc. the anesthetic
toxicity and potency
-metabolism occurs primarily in the liver with approximately 10 to 15%of the drug level metabolized per hour
-a desulfuration rxn in liver produces pentobarbital which under goes oxidative metabolism yielding 2 compounds with no anesthetic activity
-less than 1% of the drug is excreted unchanged in the urine
Sodium thiopental (pentothal)7
Ap
r 20
23
14
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
pharmacodynamicsCNS: barbiturates interact with chloride ion channels by
altering the duration they spend in an open state-this facilitates inhibitory neurotrasmitters such as gama amino
butyric acid(GABA)As well as blocking excitatory NTM actions such as glutamic acid
-thiopental will decrease both cerebral electrical & metabolic activitySo it can be used to stop seizures activity in emergency
situations-to maintain depression of cerebral electrical activity very high dose
are required-But to maintian seizure control & avoid cv depression from high
dose of thiopental other drugs are used (e.g. benzodiazepines)
7 A
pr 2
02
3
15
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
pharmacodynamics
CNS: Elevated ICP can quickly be reduced by thiopental BUT The improvement of ICP requires high dose of thiopental to be maintained
The reduction of ICP is due to cerebral vasoconstriction, reduced cerb. Metabolism &oxygen requirments associated with dec.cerebral blood volume
-theopental has an an anti-analgesic effect, since low dose may decrease pain threshold
-Intraocular pressure decreases up to 25% with 3-5mg/kg of thiopental and persists for 3 to 5 minutes
7 A
pr 2
02
3
16
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
PharmacodynamicsCVS:-thiopental causes a dose related depression
of myocardial function as measured by CO,SV, and blood pressure
-coronary blood flow, heart rate ,&myocardial oxygen uptake all increase following thiopental administration
-venous tone decreases (decreased preload)
And contributes to the increase in HR and decrease in BP
-little change in total peripheral resistance
7 A
pr 2
02
3
17
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
PharmacodynamicsRespiratory:-induction of anesthesia with
thiopental may be associated with 2 or 3 large breaths followed by apnea for less than 1min
-there is dose related depression of the respiratory response to hypercarbia and hypoxia
-laryngospasm and bronchoconstriction may be associated with light levels of thiopental and with airway manipulation or intubation
-FRC is reduced by 20% with induction of anasthesia
>Functional Residual Capacity (FRC) is the volume of air present in the lungs at the end of passive expiration.
7 A
pr 2
02
3
18
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
Pharmacodynamics GI: enzyme induction may occur with
prolonged high dose therapy - Hypoalbuminemia will result in an increase in
unbound (free) thiopental and an increase in the potency of thiopental
GU/pregnancy/fetus:- Thiopental has little or no effect on the kidneys
or gravid uterus.-although thiopental crosses the placentaIt has no significant effect on the fetus when
used for cesarean section (dose used is limited to 4mg/kg)
7 A
pr 2
02
3
19
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
Dose & administration
-the usual dose is 3-6 mg/kg- Thiopental should be used with caution
for Patients suffering from shock status because normal dose may lead to rapid death
-for a short procedure (e.g.cardioversion) a dose of 2 mg/kg is generally sufficient
-for frail elderly women with hip fracture .5-1 mg/kg may induce anesthesia
7 A
pr 2
02
3
20
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL) INDICATIONS
1- induction of anesthesia
2- maintenance of anesthesia for short procedures
3- control of convulsive states
4- for supplement of regional anesthesia or low potency anesthesia
7 A
pr 2
02
3
21
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
Absolute contraindications1- airway obstruction
2- porphyria
3- previous hypersensitivity
PRECUATIONS1- CVS disease
2- severe hepatic disease
3- renal diseases
7 A
pr 2
02
3
22
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
SIDE EFFECTS1- hypotension :if thiopental is administered to
hypovolemic, shocked or previously hypertensive pt
2- respiratory depression :when excessive doses are used
3- tissue necrosis : following venous infusion
4- laryngeal spasm
5- bronchospasm :unusual but may be precipitated in asthmatics pts
6- allergic reaction : from cutanous rashes to severe anaphylactic shock with cvs collapse
7 A
pr 2
02
3
23
Dr. M
ed. K
hale
d R
adaid
eh
SODIUM THIOPENTAL (PENTOTHAL)
SIDE EFFECTS7- Rarely, intra-arterial injection can occur.
The consequences of accidental arterial injection may be severe.
The degree of injury is related to the concentration of the drug.
Treatment consists of
1. dilution of the drug by the administration of saline into the artery,
2. heparinization to prevent thrombosis, and
3. brachial plexus block.
Overall, the proper administration of thiopental intravenously is remarkably free of local toxicity.
7 A
pr 2
02
3
24
Dr. M
ed. K
hale
d R
adaid
eh
7 A
pr 2
02
3
25
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL Intravenous
anaesthetic/hypnotic. Akylphenol. Propofol is a sweet drug
in the OR, but definitely not for home use.
7 A
pr 2
02
3
26
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL PHYSICAL AND CHEMICAL PROPERTIES
Emulsion consists of:
1% propofol 10mg/ml
10% soyabean oil.
2.25 %glycerol
1.2% purified egg phosphatide.
7 A
pr 2
02
3
27
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL PHYSICAL AND CHEMICAL PROPERTIES
so Propofol is a highly lipid soluble oil that’s combined with glycerol, egg, and soya bean oil for IV administration.
It’s appearance is similar to that of a 2% milk.
It has a pH of 7 and is supplied in 20 ml ampoules with a concentration of 10 mg/ml.
Neither precipitates histamine release nor triggers malignant hyperthermia.
Has no effects on muscle relaxants. Associated with low incidence of nausea & vomiting.
7 A
pr 2
02
3
28
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL DOSAGE
For healthy unpremedicated 2.5-3 mg/kg.
For premedicated 1.5-2 mg/kg.
Elderly patients <= 1 mg/kg.
Maintenance of anesthesia (50-150 mcg/kg/min)
combined with N2O and Opioids (Continuous
Infusion: Total intravenous Anesthesia TIVA)
For IV conscious sedation for operative procedures
with local anaesthesia 25-75 mcg/kg/min.
7 A
pr 2
02
3
29
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL EFFECTS ON ORGAN SYSTEMS
Cerebral: decreases cerebral blood flow and intracranial
pressure. Propofol has antiemetic, antipruritic, and anticonvulsant properties.
Cardiovascular: decrease in arterial blood pressure secondary to a
drop in systemic vascular resistance, contractility, and preload. Hypotension is more pronounced than with thiopental. Propofol markedly impairs the normal arterial baroreflex response to hypotension.
7 A
pr 2
02
3
30
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL EFFECTS ON ORGAN SYSTEMS
Respiratory:
propofol causes profound respiratory depression. Propofol induced depression of upper airway reflexes exceeds that of thiopental.
Venous irritation: Pain on injection is more common than with thiopental
esp. if given in a small vein in the hand.
To solve this problem:
1. small doze of lidocaine with propofol.
2. administering propofol through a fast flowing more proximal IV
catheter.
7 A
pr 2
02
3
31
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL INDICATIONS
indication Approved Patient Population
Initiation and maintenance of Monitored Anesthesia Care sedation
Adults only
Combined sedation and regional anesthesia
Adults only (See PRECAUTIONS)
Induction of General Anesthesia Patients ≥ 3 years of age
Mainenance of General Anesthesia Patients ≥ 2 months of age
Intensive Care Unit (ICU) sedation of intubated, mechanically ventilated patients
Adults only
7 A
pr 2
02
3
32
Dr. M
ed. K
hale
d R
adaid
eh
PROPOFOL CONTRAINDICATIONS
1. Egg allergy.
2. Lack of resuscitation equipment or knowledge of the drug.
3. Inability to maintain a patent airway.
4. Conditions in which reduction in blood pressure can’t be tolerated. E.g. patients with fixed cardiac output (severe aortic or mitral stenosis, IHSS, pericardial tamponade) and those in shock status.
7 A
pr 2
02
3
33
Dr. M
ed. K
hale
d R
adaid
eh
KETAMINE
It’s a dissociative anesthetic
agent.
by dissociative we mean that
the patient is unconscious but
appears awake and doesn’t
feel pain.
It has anesthetic and
analgesic effect
7 A
pr 2
02
3
34
Dr. M
ed. K
hale
d R
adaid
eh
KETAMINE PHYSICAL & CHEMICAL PROPERTIES
7 A
pr 2
02
3
35
Dr. M
ed. K
hale
d R
adaid
eh
chemically related to the psychotropic drug ( e.g. phencyclidine).
Water soluble, and 10x more lipid soluble than thiopental.
pH=3.5 - 5.5
KETAMINE PHARMACOKINETICS
ROUTE OF ADMINISTRATION
I.V. : 2mg/kgIM.Oral.Rectal. Needs higher doze due to
extensive first pass metabolism and decreased absorption.
7 A
pr 2
02
3
36
Dr. M
ed. K
hale
d R
adaid
eh
KETAMINE PHARMACOKINETICS
DOSAGE
IM 5 – 10 mg/kg. peak plasma level reach approx 15 minutes
IV 1 – 2 mg/kg. dissociated stage is
noted in 15 seconds. intense analgesia, amnesia & unconciousness occur within 45-60 minutes
subsequent IV doses of 1/3 – ½ of the initial dose maybe required
7 A
pr 2
02
3
37
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE METABOLISM
It has a rapid absorption and distribution to the vessel rich groups like THIOPENTAL
Hepatic metabolism is required for elimination <5% excreted unchanged in urine
7 A
pr 2
02
3
38
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE MECHANISM OF ACTION
There are 3 theories explains the MOA of ketamines :
1 – N-methyl aspartate receptor theory :
NMA receptors may represent a subgroup of the sigma opiate receptors (the PCP site) that blocks spinal pain reflexes.
2 – Opiate receptor theory :
Ketamine may have some affinity for opiate receptors but it’s effect can’t be reversed with naloxone.
3- Miscellaneous receptor theory :
It reacts with muscarinic, cholinergic and serotonergic receptors. Ketamine is a potent analgesic at subanesthetic plasma
concentrations. It has a wide margin of safety ( up to 10x the usual dose )
7 A
pr 2
02
3
39
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE PHARMACODYNAMICS
CNS :1. ketamine increases cerebral oxygen
consumption, cerebral blood flow, and intracranial pressure
2- generalized increase in the muscle tone and purposful movements.
3- Unpleasant dreams, hallucinations or frank delirium (esp. females & large doze of ketamine).
incidence of dilirium in 15-35 year old pts is approx. 20%
7 A
pr 2
02
3
40
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE PHARMACODYNAMICS
Respiratory system:It preserves laryngeal &pharyngeal airway reflexes.
• Ketamine is a potent bronchodilator. • The CO2 response curve is shifted to the left with its
slope unchanged (similar to opiates). FRC unchaged. Minute ventilation unchanged. Tidal volume unchanged. Hypoxic pulmonary vasoconstriction unchanged. Ketamine causes increased secretions but this can be
limited by anti-cholinergic drugs.
7 A
pr 2
02
3
41
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE PHARMACODYNAMICS
CVS:• It produces central sympathetic stimulation,
which increases: 1. arterial blood pressure, heart rate, and cardiac
output. 2. Pulmonary artery pressure.3. Coronary blood flow.4. Myocardail oxygen uptake. It may cause myocardial depression if the
sympathetic nervous sys is exhausted or blocked.
7 A
pr 2
02
3
42
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE PHARMACODYNAMICS
GI Minimal anorexia, nausea & vomiting.
GUPlacental transfer does occur, but neonatal depression hasn’t
been observed if the doze is limited to < 1 mg/kg.
Muscle system Generalized increase in skeletal muscle tone. Increases the effects of muscle relaxants.
Endocrine Sys. Increased sympathetic stimulation increased blood
glucose, increased plasma cortisol, increased heart rate.
7 A
pr 2
02
3
43
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE INDICATIONS
1- sole anesthetic for diagnosis and surgical procedures
2- induction of anesthesia
3- to supplement regional or local anesthetic techniques
4- for anesthetic induction in severe asthmatic pts. Or patients with cardiovascular collapse requiring emergency surgery
7 A
pr 2
02
3
44
Dr. M
ed. K
hale
d R
adaid
eh
KETMINE CONTRAINDICATIONS
1- lack of knowledge of the drug
2- lack of resuscitative equipment
3- inability to maintain a patent airways
4- allergy to ketamine
5- history of psychosis
6- cerebro-vascular disease
7- Patients. For whom hypertention is hazardous
7 A
pr 2
02
3
45
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINES
Features which result in their popularity as adjuvant IV anaesthetic agents:
1 – amnesia2 – minimal cardiarespiretory
depressant effect.3 – anticonvulsant activity.4 – low incidence of tolerance and
dependence.
7 A
pr 2
02
3
46
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINES MODE OF ACTION
1 – They inhibit the actions of glycine (by increasing the conc. Of a glycine inhibitory neurotransmitter) which will lead to antianxiety and skeletal muscle relaxant effects.
2 – They facilitate the actions of the inhibitory neurotransmitter GABA which results in the sedative and anticonvulsant effects.
Benzodiazepines are highly lipid soluble. They are highly protein bound (albumin). They are metabolized by the liver through conjugation with
glucoronic acid and excreted by the kidneys. Midazolam and Diazepam are the most commonly used
benzodiazepines during operative procedures.
7 A
pr 2
02
3
47
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINES MIDAZOLAM AND DIAZEPAM
They are commonly used to provide:
1- IV sedation.
2- amnesia.
3- reducing anxiety.
7 A
pr 2
02
3
48
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINES MIDAZOLAM AND DIAZEPAM
THE DIFFERENCES BETWEEN THEM 1- Midazolam is 2-3 times more potent than
diazepam:
2- The dose for IV conscious sedation: 0.5 – 3 mg up to 0.1 mg/kg for midazolam, and 1-10 mg for diazepam.
3- The dose for inducing anesthesia: 0.2 – 0.4 mg/kg for midazolam , and 0.15-1.5 mg/kg for diazepam.
4- Midazolam has a more rapid onset, greater amnestic effect, less postoperative sedative effects than diazepam.
7 A
pr 2
02
3
49
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINES MIDAZOLAM AND DIAZEPAM
THE DIFFERENCES BETWEEN THEM 5- Pain on injection and subsequent
thrombophlebitis is less likely with midazolam (an emulsion of diazepam)
6- Midazolam is more costly than diazepam).
7- Midazolam’s duration of action is less than diazepam but almost 3 times that of thiopental.
8- Elimination half time for midazolam range from 1-4 hours, and for diazepam from 21-37 hours.
9- Midazolam is supplied as a clear liquid in concentrations of 1-5 mg/ml.
7 A
pr 2
02
3
50
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINE ANTAGONISTS (FLUMAZENIL)
It’s an imidazobenzodiazepine.
It specifically antagonizes benzodiazepine’s central
effects by copetative inhibition.
It’s elimination half-time is one hour, considerably less
than most benzodiazepines; therefore we will need
repeated administrations of flumazenil to antagonize a
benzodiazepine with a longer half-time.
7 A
pr 2
02
3
51
Dr. M
ed. K
hale
d R
adaid
eh
BENZODIAZEPINE ANTAGONISTS (FLUMAZENIL)
Flumazenil is supplied as a colourless liquid in a concentration of 0.1 mg/ml.
The usual initial dose is 0.2 mg over 15 seconds, if the desired level of consiousness is not obtained within one minute of administration we can give repeated doses of 0.1 mg every minute up to the maximum of 2 mg, and if sedation recurs we can use infusions of 0.1-0.4 mg/hour.
Flumazenil is well tolerated. The most common side is nausea (4% of
patients).
7 A
pr 2
02
3
52
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTS
Opium derived from dried juice of poppy plant which contains over 20 plant alkaloids. including morphine & codiene.
7 A
pr 2
02
3
53
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTSSITE OF ACTION
Opioid receptors are predominantly located in the:
1. Brain stem (amygdala, corpus striatum, periaqueductal gray matter and medulla).
2. Spinal cord(substantia gelatinosa).
3. GIT. They act on 3 types of receptors:
1. Mu receptors (μ): analgesia, respiratory depression, euphoria, & physical dependence.
2. Kappa receptors (K): analgesia, sedation, respiratory depression, miosis.
3. Segma receptors(a): dysphoria, hallucination, tachypnea, tachycardia.
7 A
pr 2
02
3
54
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTS PHARMACOKINETICS
Rapid distribution through the body
following IV injection.
It’s metabolized by the liver and the
majority of the inactive metabolites are
excreted unchanged in the urine.
7 A
pr 2
02
3
55
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTS PHARMACODYNAMICS
CNS:Opioids sedate through interfering with sensory perception of painful stimuli.
large doses produce unconsciousness but they are generally incapable of producing anesthesia and it can’t guarantee total amnesia.
It may produce nausea & emesis through stimulation of the chemoreceptor trigger zone.
7 A
pr 2
02
3
56
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTS PHARMACODYNAMICS
RespiratoryThey result in dose related depression
of respiratory rate and minute ventilation and increase the tidal volume which will lead to a slow deep respiration. Reversed by naloxone administration.
7 A
pr 2
02
3
57
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTS PHARMACODYNAMICS
CVS Opioids have little myocardial depressant effect even
when administered in high doses. Supplementation with either N2O or benzodiazepines
may depress cardiac output. They decrease systemic vascular resistance either by
decreasing sympathetic outflow or by releasing histamine (as morphine) which produces vasodilation & decrease SVR.
Synthetic opioids are less likely to release histamine. They produce bradycardia by stimulation vagal
nucleus in the brain stem.
7 A
pr 2
02
3
58
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTS PHARMACODYNAMICS
GIT Narcotics slow GI mobility and may result in
constipation or post operative ileus. All narcotics increase biliary tract tone which
may lead to biliary colic with patients with bile stones.
Others Increases the bladder sphincter’s tone urine
retention. Anaphylactic reactions, bronchospasm, chest
wall rigidity and pruritis.
7 A
pr 2
02
3
59
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTSFENTANYL AND MORPHINEFentanyl is the most narcotic agent used
during induction of anaesthesia due to its rapid onset (highly lipid soluble) and predictable duration of action (30 minutes).
Morphine is used in the perioperative period to provide long lasting analgesia. And it should be administered slowly at a rate < 5 mg/min to avoid excessive histamine release.
7 A
pr 2
02
3
60
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC AGONISTSFENTANYL AND MORPHINE
Potency Ratio Analgesic dose Low dose
Morphine 1 10 mg 0.05 - 0.2 mg/kg
Fentanyl 100 100 mcg 0.5 – 3 mic g/kg
7 A
pr 2
02
3
61
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC ANTAGONISTS (NALOXONE)
Naloxone competes with opioids at the mu, delta,
kappa and sigma receptors.
Ampules of 0.02, 0.4 and 1 mg/ml.
Peak effect 1-2 min.
Duration of action 30-60 min.
Used in perioperative surgical patients with excessive
sedation or respiratory sedation secondary to
opioids.
7 A
pr 2
02
3
62
Dr. M
ed. K
hale
d R
adaid
eh
NARCOTIC ANTAGONISTS (NALOXONE)
Given in small incremental doses. High doses of naloxone will result in sudden
reversal of analgesic effects leading to abrupt return of pain resulting in hypertension, tachycardia, pulmonary edema, ventricular dysrhythmias and cardiac arrests.
If sedation or respiratory depression recurs, continuous infusion of 3-10 micg/kg/hour of naloxone is required.
7 A
pr 2
02
3
63
Dr. M
ed. K
hale
d R
adaid
eh
ANAESTHESIA THANK YOU 7
Ap
r 20
23
64
Dr. M
ed. K
hale
d R
adaid
eh
INTRAVENOUS ANAESTHETIC
AGENTS
Thank you
Dr. Med. Khaled Radaideh
Department of Anesthesiology - Jordan University of Science and Technology Irbid-Jordan
7 A
pr 2
02
3
65
Dr. M
ed. K
hale
d R
adaid
eh